Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Record History shows an addition of Revision: v3.3.2 and a deletion of Revision: v3.3.1 in the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:26:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new history entry: Revision v3.3.1. The previous Revision v3.2.0 entry has been removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:36:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding notice/banner about operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:47:03.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The history shows multiple updates to study status and recruitment status across versions, reflecting changes in trial activity and enrollment over time.
    Difference
    0.1%
    Check dated 2025-11-03T01:16:16.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T10:05:49.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:43.000Z thumbnail image

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.